Pharma Giant Cipla Slapped with ₹774 Crore Income Tax Demand Amid New Obesity Drug Launch

Mumbai-based Cipla faces massive income tax demand of ₹774 crore over rule violations, including short deductions and disallowance of expenses, amid the launch of its new obesity drug.

CiplaIncome Tax DemandRule ViolationsObesity DrugPharmaceutical IndustryReal Estate MumbaiJul 16, 2024

Pharma Giant Cipla Slapped with ₹774 Crore Income Tax Demand Amid New Obesity Drug Launch
Real Estate Mumbai:Cipla, a leading pharmaceutical company based in Mumbai, has been handed a massive income tax demand of ₹774 crore. The demand notice cites additional taxes for rule violations, including short deductions, weighted deductions, and disallowance of expenses. This development comes at a time when the company is preparing to launch a new obesity drug.

The income tax demand of ₹773.44 crore covers assessment years from 2015-16 to 2022-23, excluding any tax refunds. Cipla has confirmed the demand in its regulatory filings and plans to appeal against the tax order. The company has stated that the tax demands are not applicable under the law.

The tax authorities have cited rule violations, including short deductions, wherein the company deducted less tax than the rate mentioned in the provisions. Additionally, weighted deductions allowed for companies to invest in the development of knowledge and research capabilities were also disallowed, as well as expenses incurred for business operations.

Cipla is a well-established pharmaceutical company that has been operating in India for over 80 years. The company has a strong presence in the domestic market and exports its products to over 80 countries worldwide. Despite the income tax demand, Cipla remains committed to its mission of providing affordable and innovative healthcare solutions to patients globally.

Information
Cipla is an Indian multinational pharmaceutical company that was founded in 1935. The company is headquartered in Mumbai and has a strong presence in the domestic market. Cipla is known for its innovative and affordable healthcare solutions and has a global footprint, with exports to over 80 countries.

Cipla is a leading pharmaceutical company that has been operating in India for over 80 years. The company is committed to providing innovative and affordable healthcare solutions to patients globally.

Frequently Asked Questions

What is the amount of income tax demand slapped on Cipla?

The income tax demand on Cipla is ₹774 crore.

What are the rule violations cited by the tax authorities?

The tax authorities have cited rule violations, including short deductions, weighted deductions, and disallowance of expenses.

What is Cipla's response to the income tax demand?

Cipla has stated that the tax demands are not applicable under the law and plans to appeal against the tax order.

What is the significance of the income tax demand on Cipla?

The income tax demand on Cipla is significant as it comes at a time when the company is preparing to launch a new obesity drug, and may impact its financial performance.

What is Cipla's commitment to its customers?

Cipla remains committed to its mission of providing affordable and innovative healthcare solutions to patients globally, despite the income tax demand.

Related News Articles

Unlocking Opportunities in the Real Estate Insurance Market: Trends, Insights, and Projections
Real Estate

Unlocking Opportunities in the Real Estate Insurance Market: Trends, Insights, and Projections

Discover the latest trends, challenges, and opportunities in the real estate insurance market, featuring key players, regional analysis, and market segmentation.

June 22, 2024
Read Article
Pune Real Estate Market Sees 50% Jump in Registered Transactions, Average Home Price Reaches Record High
Real Estate Pune

Pune Real Estate Market Sees 50% Jump in Registered Transactions, Average Home Price Reaches Record High

The number of real estate transactions in Pune has increased significantly, with registered transactions surging by 50% in the April-June 2024 quarter.

August 12, 2024
Read Article
Haryana and Jammu & Kashmir Assembly Election Dates Announced by EC; Results to be Declared on October 4
Real Estate Mumbai

Haryana and Jammu & Kashmir Assembly Election Dates Announced by EC; Results to be Declared on October 4

The Election Commission of India has announced the dates for the Haryana and Jammu & Kashmir assembly elections. The polls will be held in a single phase on October 21, and the results will be declared on October 4.

August 16, 2024
Read Article
Century Textiles Acquires 10-Acre Land in Mumbai for ₹1100 Crore, Expects ₹14,000 Crore in Revenue
Real Estate

Century Textiles Acquires 10-Acre Land in Mumbai for ₹1100 Crore, Expects ₹14,000 Crore in Revenue

Century Textiles plans to develop the land through its real estate subsidiary Birla Estates, expecting ₹14,000 crore in revenue from the project.

September 10, 2024
Read Article
Virgo Daily Horoscope for September 14, 2024: A Temporary Setback in Assets and Real Estate Deals
real estate news

Virgo Daily Horoscope for September 14, 2024: A Temporary Setback in Assets and Real Estate Deals

Be cautious with real estate deals today, as a temporary decline in assets may occur. However, this setback will be short-lived.

September 14, 2024
Read Article
DLF Q2 Earnings Skyrocket: Net Profit Surges to ₹1381 Crore
real estate news

DLF Q2 Earnings Skyrocket: Net Profit Surges to ₹1381 Crore

DLF, India's leading real estate firm in terms of market capitalization, has reported a remarkable surge in its Q2 net profit, jumping over twofold to ₹1381 crore. The company, primarily engaged in the development and sale of residential and commercial pr

October 25, 2024
Read Article